[ACOUNEU-radiosurgery or hypofractionated radiotherapy for sporadic vestibular schwannoma] [0.03%]
单发听神经瘤的治疗：立体定向放射外科手术与低分割放疗的比较研究
Christoph Straube,Lukas Käsmann,Michal Devecka
Christoph Straube
Proton beam therapy versus trans-arterial chemoembolization for BCLC stage B hepatocellular carcinoma-a propensity-matched analysis [0.03%]
质子束治疗与经动脉化疗栓塞治疗BCLC B期肝细胞癌的倾向匹配分析
Tzu-Ting Liu,Bing-Shen Huang,Yu-Ming Wang et al.
Tzu-Ting Liu et al.
Purpose: Proton beam therapy (PBT) has a promising local control rate, but clinical data supporting its use for intermediate-stage hepatocellular carcinoma (HCC) remains insufficient, and its survival benefit over transar...
Automated quality assurance of imaging dose and protocol adherence in computed tomography radiotherapy planning using TotalSegmentator-based segmentation [0.03%]
基于TotalSegmentator分割的计算机断层摄影放疗计划成像剂量和协议的自动质量保证
Niklas A Lackner,Andre Karius,Tobias Brandt et al.
Niklas A Lackner et al.
Purpose: Computed tomography (CT) scans are vital for radiotherapy planning, providing essential data for dose calculations. This study retrospectively evaluated imaging doses, scan lengths, and protocol adherence to supp...
From fractionation to financials: economic and clinical implications of hypofractionation in German outpatient radiotherapy practice [0.03%]
从分割到财务：德国门诊放射治疗实践中的低分割经济和临床影响
Anastassia Löser,Monika Huth,Akvile Juskeviciute et al.
Anastassia Löser et al.
Background and objective: Thie study aimed to examine the economic implications of different radiotherapy fractionation schemes, specifically normofractionation (NF) and hypofractionation (HF), for breast and prostate can...
[Radiation protection procedures in the context of the new Medical Research Act: what has changed, what has not? A joint overview by the German Society for Radiation Oncology (DEGRO) and the Federal Office for Radiation Protection (BfS)] [0.03%]
[新的医疗研究法背景下的放射防护程序：有哪些改变，哪些未变？德国放射肿瘤学会（DEGRO）和联邦辐射防护局（BfS）联合综述]
Elena Sperk,Matthias Habeck,Felix Giani et al.
Elena Sperk et al.
Correction to: From protocol to practice: long-Term outcomes of single-Fraction stereotactic body radiotherapy for primary non-Small cell lung cancer [0.03%]
单次分段立体定向体部放射治疗原发性非小细胞肺癌的长期结果（《从方案到实践》的更正）
Kerem Tuna Tas,Philipp Lishewski,Fatima Frosan Sheikhzadeh et al.
Kerem Tuna Tas et al.
[Perioperative immune checkpoint inhibition with pembrolizumab in combination with adjuvant therapy improves event-free survival for operable locally advanced head and neck tumors] [0.03%]
帕博利珠单抗联合辅助治疗可改善局部晚期可手术头颈部肿瘤患者的无事件生存期：一项围手术期免疫检查点抑制研究
Sören Schnellhardt,Panagiotis Balermpas,Markus Hecht
Sören Schnellhardt
Role of primary chemoradiotherapy in the management of advanced stage vulvar cancer : Experience of a large cancer center [0.03%]
术前同步放化疗在晚期外阴癌综合治疗中的作用及体会——单中心大宗病例报道
Lars Wessel,Maria Vinsensia,Thomas Koenigsmann et al.
Lars Wessel et al.
Purpose: Treatment of advanced vulvar cancer is challenging. The aim of the study was to investigate the potential of primary (chemo)radiotherapy ((C)RT) with regard to clinical outcome and associated prognostic parameter...
Research with cancer registry data in radiation oncology-current possibilities and perspectives : A narrative review [0.03%]
放射肿瘤学中的癌症登记数据研究：当前的可能性和展望——叙述性综述
Jörg Andreas Müller,Ahmed Bedir,Alexander Katalinic et al.
Jörg Andreas Müller et al.
Clinical background: Cancer registry data are an essential resource for population-based oncology research and quality assurance in Germany. With the revision of the Federal Cancer Registry Data Act in 2021, for the first...
Does transurethral resection of prostate increase toxicity risk after simultaneous integrated boost radiotherapy? A matched cohort study with long-term follow-up [0.03%]
经尿道前列腺切除术会增加同时集成加速放射治疗的毒性风险吗？一项长期随访匹配队列研究
Aysenur Elmali,Birhan Demirhan,Ozan Cem Guler et al.
Aysenur Elmali et al.
Purpose: To evaluate genitourinary (GU) toxicity in patients with prostate cancer receiving conventional radiotherapy (RT) with a simultaneous integrated boost (SIB) to intraprostatic lesions (IPL), with a specific focus ...